Another study [41] revealed that HYC16, a kind of cationic lipid modification of hydrocortisone, exhibited significantly less VEGFR2 expression and lower density of vascular endothelial cells in mice, indicating HYC16 had an evident anti-angiogenic effect and substantiated its ability to inhibit tumor growth. This evidence concerns the gene KDR and neoplasm.